skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Discovery of potent and orally active 1,4-disubstituted indazoles as novel allosteric glucokinase activators

Authors:
; ; ; ; ; ; ; ; ; ;
Publication Date:
Sponsoring Org.:
USDOE
OSTI Identifier:
1416584
Resource Type:
Journal Article: Publisher's Accepted Manuscript
Journal Name:
Bioorganic and Medicinal Chemistry Letters
Additional Journal Information:
Journal Name: Bioorganic and Medicinal Chemistry Letters Journal Volume: 27 Journal Issue: 12; Journal ID: ISSN 0960-894X
Publisher:
Elsevier
Country of Publication:
United Kingdom
Language:
English

Citation Formats

Cheruvallath, Zacharia S., Gwaltney, II, Stephen L., Sabat, Mark, Tang, Mingnam, Wang, Haixia, Jennings, Andy, Hosfield, David, Lee, Bumsup, Wu, Yiqin, Halkowycz, Petro, and Grimshaw, Charles E. Discovery of potent and orally active 1,4-disubstituted indazoles as novel allosteric glucokinase activators. United Kingdom: N. p., 2017. Web. doi:10.1016/j.bmcl.2017.04.041.
Cheruvallath, Zacharia S., Gwaltney, II, Stephen L., Sabat, Mark, Tang, Mingnam, Wang, Haixia, Jennings, Andy, Hosfield, David, Lee, Bumsup, Wu, Yiqin, Halkowycz, Petro, & Grimshaw, Charles E. Discovery of potent and orally active 1,4-disubstituted indazoles as novel allosteric glucokinase activators. United Kingdom. https://doi.org/10.1016/j.bmcl.2017.04.041
Cheruvallath, Zacharia S., Gwaltney, II, Stephen L., Sabat, Mark, Tang, Mingnam, Wang, Haixia, Jennings, Andy, Hosfield, David, Lee, Bumsup, Wu, Yiqin, Halkowycz, Petro, and Grimshaw, Charles E. 2017. "Discovery of potent and orally active 1,4-disubstituted indazoles as novel allosteric glucokinase activators". United Kingdom. https://doi.org/10.1016/j.bmcl.2017.04.041.
@article{osti_1416584,
title = {Discovery of potent and orally active 1,4-disubstituted indazoles as novel allosteric glucokinase activators},
author = {Cheruvallath, Zacharia S. and Gwaltney, II, Stephen L. and Sabat, Mark and Tang, Mingnam and Wang, Haixia and Jennings, Andy and Hosfield, David and Lee, Bumsup and Wu, Yiqin and Halkowycz, Petro and Grimshaw, Charles E.},
abstractNote = {},
doi = {10.1016/j.bmcl.2017.04.041},
url = {https://www.osti.gov/biblio/1416584}, journal = {Bioorganic and Medicinal Chemistry Letters},
issn = {0960-894X},
number = 12,
volume = 27,
place = {United Kingdom},
year = {Thu Jun 01 00:00:00 EDT 2017},
month = {Thu Jun 01 00:00:00 EDT 2017}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record at https://doi.org/10.1016/j.bmcl.2017.04.041

Citation Metrics:
Cited by: 16 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Type 2 diabetes market
journal, May 2005


Initial Management of Glycemia in Type 2 Diabetes Mellitus
journal, October 2002


Insulin sensitisation in the treatment of Type 2 diabetes
journal, March 2003


Design, synthesis and SAR of novel glucokinase activators
journal, April 2013


Glucokinase Activators for Diabetes Therapy: May 2010 status report
journal, April 2011


Insights into the Structure and Regulation of Glucokinase from a Novel Mutation (V62M), Which Causes Maturity-onset Diabetes of the Young
journal, April 2005


Small molecule glucokinase activators as novel anti-diabetic agents
journal, April 2005


Pyridones as glucokinase activators: Identification of a unique metabolic liability of the 4-sulfonyl-2-pyridone heterocycle
journal, June 2009


Glucokinase and glucose homeostasis: proven concepts and new ideas
journal, February 2005


Regulation of Pancreatic  -Cell Glucokinase: From Basics to Therapeutics
journal, December 2002


Balancing hERG affinity and absorption in the discovery of AZD5672, an orally active CCR5 antagonist for the treatment of rheumatoid arthritis
journal, February 2012